Vertex Ventures HC

• 05 Dec 2022 SonoThera™ Completes $60
• 75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development SonoThera™ Completes $60 75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development
• 31 Oct 2022 Advice for Managing Downturns: Don't Panic Advice for Managing Downturns: Don't Panic
• 28 Sept 2022 EPISODE 17- The Three Pillars Of Bio & Medtech Investing And Industry Impact Of DEI EPISODE 17- The Three Pillars Of Bio & Medtech Investing And Industry Impact Of DEI Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases We're excited to share Palleon Pharmaceuticals scientific co-founder Carolyn Bertozzi, Ph D , has been awarded the 2022 Nobel Prize in Chemistry

Dr Bertozzi’s deep contributions were not only to chemistry but to biology and medicine, including the foundational science underlying Palleon’s first-in-class, clinical-stage therapeutic platform She also invented bioorthogonal chemistry which enabled foundational discoveries in glycobiology and pioneered translation of this field into a new area of drug development

Check out our short clip on Palleon Pharmaceuticals and their scientific co-founder Carolyn Bertozzi below

Palleon Pharmaceuticals is a biotechnology company pioneering glyco-immunology drug development to transform the treatment of cancer and inflammatory diseases Today, Palleon is advancing a rich clinical-stage pipeline of therapeutic candidates in immuno-oncology and inflammatory disorders which has the potential to impact millions of patients worldwide

Find out more: https://palleonpharma com/